- Home
- CIO vs VYGR Comparison
CIO vs VYGR Comparison
Compare CIO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- VYGR
- Stock Information
- Founded
- CIO 2013
- VYGR 2013
- Country
- CIO Canada
- VYGR United States
- Employees
- CIO N/A
- VYGR N/A
- Industry
- CIO Real Estate Investment Trusts
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- CIO Real Estate
- VYGR Health Care
- Exchange
- CIO Nasdaq
- VYGR Nasdaq
- Market Cap
- CIO 202.0M
- VYGR 191.9M
- IPO Year
- CIO 2014
- VYGR 2015
- Fundamental
- Price
- CIO $4.92
- VYGR $3.28
- Analyst Decision
- CIO
- VYGR Strong Buy
- Analyst Count
- CIO 0
- VYGR 9
- Target Price
- CIO N/A
- VYGR $14.86
- AVG Volume (30 Days)
- CIO 176.3K
- VYGR 324.3K
- Earning Date
- CIO 05-02-2025
- VYGR 05-06-2025
- Dividend Yield
- CIO 8.10%
- VYGR N/A
- EPS Growth
- CIO N/A
- VYGR N/A
- EPS
- CIO N/A
- VYGR N/A
- Revenue
- CIO $168,891,000.00
- VYGR $66,958,000.00
- Revenue This Year
- CIO $1.25
- VYGR N/A
- Revenue Next Year
- CIO $3.42
- VYGR $2.04
- P/E Ratio
- CIO N/A
- VYGR N/A
- Revenue Growth
- CIO N/A
- VYGR N/A
- 52 Week Low
- CIO $4.19
- VYGR $2.75
- 52 Week High
- CIO $6.50
- VYGR $9.55
- Technical
- Relative Strength Index (RSI)
- CIO 49.31
- VYGR 45.06
- Support Level
- CIO $4.78
- VYGR $3.46
- Resistance Level
- CIO $5.09
- VYGR $3.54
- Average True Range (ATR)
- CIO 0.17
- VYGR 0.19
- MACD
- CIO -0.00
- VYGR -0.00
- Stochastic Oscillator
- CIO 28.28
- VYGR 21.15
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.